| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Note of Thanks
|
|
|
2016
|
38 |
12 |
p. A6-A8
|
article
|
| 2 |
Associations Between Vaginal Infections and Potential High-risk and High-risk Human Papillomavirus Genotypes in Female Sex Workers in Western Kenya
|
Menon, Sonia
|
|
2016
|
38 |
12 |
p. 2567-2577
|
article
|
| 3 |
Author Index
|
|
|
2016
|
38 |
12 |
p. 2691-2698
|
article
|
| 4 |
Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis
|
Chuma, Masayuki
|
|
2016
|
38 |
12 |
p. 2598-2609
|
article
|
| 5 |
Editorial Board
|
|
|
2016
|
38 |
12 |
p. A2
|
article
|
| 6 |
Effect of Modulated Electrohyperthermia on the Pharmacokinetics of Oral Transmucosal Fentanyl Citrate in Healthy Volunteers
|
Lee, Sun Young
|
|
2016
|
38 |
12 |
p. 2548-2554
|
article
|
| 7 |
Effects of Glimepiride versus Saxagliptin on β-Cell Function and Hypoglycemia: A Post Hoc Analysis in Older Patients with Type 2 Diabetes Inadequately Controlled with Metformin
|
Perl, Shira
|
|
2016
|
38 |
12 |
p. 2578-2588
|
article
|
| 8 |
Evaluation of 16 genotype-guided Warfarin Dosing Algorithms in 310 Korean Patients Receiving Warfarin Treatment: Poor Prediction Performance in VKORC1 1173C Carriers
|
Yang, Mina
|
|
2016
|
38 |
12 |
p. 2666-2674.e1
|
article
|
| 9 |
Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive-controlled Crossover QT/QTc Study in Healthy Subjects
|
Zhou, Diansong
|
|
2016
|
38 |
12 |
p. 2555-2566
|
article
|
| 10 |
Glycemic Control and Weight Outcomes for Exenatide Once Weekly Versus Liraglutide in Patients with Type 2 Diabetes: A 1-Year Retrospective Cohort Analysis
|
McAdam-Marx, Carrie
|
|
2016
|
38 |
12 |
p. 2642-2651
|
article
|
| 11 |
Intervention Studies of Inhaled Corticosteroids Combined with Long-acting Theophylline or Long-acting β2-agonists in Patients with Moderate to Severe Asthma: A Randomized, Controlled Study
|
Wang, Yan
|
|
2016
|
38 |
12 |
p. 2622-2627.e1
|
article
|
| 12 |
Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056)
|
Ufer, Mike
|
|
2016
|
38 |
12 |
p. 2589-2597
|
article
|
| 13 |
Patterns and Trends in Scientific Research on Generic Drugs
|
Lucas-Dominguez, Rut
|
|
2016
|
38 |
12 |
p. 2684-2689.e1
|
article
|
| 14 |
Pharmacovigilance and Biomedical Informatics: A Model for Future Development
|
Beninger, Paul
|
|
2016
|
38 |
12 |
p. 2514-2525
|
article
|
| 15 |
Pharmacovigilance in the New Millennium
|
Beninger, Paul
|
|
2016
|
38 |
12 |
p. 2512-2513
|
article
|
| 16 |
Population Pharmacokinetic–Pharmacodynamic Analysis to Compare the Effect of Moxifloxacin on QT Interval Prolongation Between Healthy Korean and Japanese Subjects
|
Choi, Hyang-Ki
|
|
2016
|
38 |
12 |
p. 2610-2621
|
article
|
| 17 |
SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis
|
Goldenberg, Ronald M.
|
|
2016
|
38 |
12 |
p. 2654-2664.e1
|
article
|
| 18 |
Some Thoughts on Pharmacovigilance and Postmarketing Surveillance
|
Shader, Richard I.
|
|
2016
|
38 |
12 |
p. 2509-2510
|
article
|
| 19 |
Subject Index
|
|
|
2016
|
38 |
12 |
p. 2699-2709
|
article
|
| 20 |
Table of Contents
|
|
|
2016
|
38 |
12 |
p. A4-A5
|
article
|
| 21 |
The US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy (REMS) Program – Current Status and Future Direction
|
Wu, Jasmanda
|
|
2016
|
38 |
12 |
p. 2526-2532
|
article
|
| 22 |
Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis
|
Vieira, Maria-Cecilia
|
|
2016
|
38 |
12 |
p. 2628-2641.e5
|
article
|
| 23 |
Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectives
|
Mullins, C. Daniel
|
|
2016
|
38 |
12 |
p. 2676-2681
|
article
|
| 24 |
What Can Big Data Offer the Pharmacovigilance of Orphan Drugs?
|
Price, John
|
|
2016
|
38 |
12 |
p. 2533-2545
|
article
|
Journal description